Research location
Torrington
Connecticut, United States
Advertisement
Research activity in Torrington
Connecticut, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 98 trials and 99 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Torrington
98 linked trials · page 2 of 2Lung-MAP: Durvalumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching BiomarkersNCT02766335 · 2014-07-31 · 1 site observation
COMPLETED
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung CancerNCT02154490 · 2014-07-08 · 1 site observation
COMPLETED
Lung-MAP: Rilotumumab and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and Positive Biomarker MatchesNCT02926638 · 2014-06-16 · 1 site observation
TERMINATED
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast CancerNCT02032823 · 2014-04-22 · 1 site observation
ACTIVE_NOT_RECRUITING
Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or MetastaticNCT02115282 · 2014-03-29 · 1 site observation
ACTIVE_NOT_RECRUITING
Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing SurgeryNCT01953588 · 2014-02-27 · 1 site observation
ACTIVE_NOT_RECRUITING
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast CancerNCT01674140 · 2013-09-12 · 1 site observation
ACTIVE_NOT_RECRUITING
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast CancerNCT01272037 · 2011-02-28 · 1 site observation
ACTIVE_NOT_RECRUITING
Imetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or Metastatic Breast CancerNCT01256762 · 2010-11-01 · 1 site observation
COMPLETED
A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast CancerNCT01101438 · 2010-08-13 · 1 site observation
COMPLETED
Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung CancerNCT00955305 · 2010-03-01 · 1 site observation
TERMINATED
A Study for Participants With Small-Cell Lung CancerNCT01025284 · 2009-12-01 · 1 site observation
COMPLETED
A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive StageNCT00887159 · 2009-07-16 · 1 site observation
COMPLETED
Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast CancerNCT00878709 · 2009-07-09 · 1 site observation
COMPLETED
Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLCNCT00828841 · 2008-12-01 · 1 site observation
COMPLETED
A Randomized Phase 2 Study of Erlotinib + ARQ 197 Versus Erlotinib + Placebo in Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)NCT00777309 · 2008-09-01 · 1 site observation
COMPLETED
Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast CancerNCT00433511 · 2007-11-02 · 1 site observation
ACTIVE_NOT_RECRUITING
GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung CancerNCT00480025 · 2007-10-04 · 1 site observation
TERMINATED
A Phase 2 Trial of Standard Chemotherapy, With or Without BSI-201, in Patients With Triple Negative Metastatic Breast CancerNCT00540358 · 2007-10-01 · 1 site observation
COMPLETED
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By SurgeryNCT00324805 · 2007-07-19 · 1 site observation
COMPLETED
Adj TC + Herceptin Early Stage Breast CancerNCT00493649 · 2007-06-01 · 1 site observation
COMPLETED
An Efficacy Study of Trabectedin in the Treatment of Participants With Specific Subtypes of Metastatic Breast CancerNCT00580112 · 2007-06-01 · 1 site observation
COMPLETED
Phase II Sunitinib Prog Met AIPCNCT00599313 · 2007-03-01 · 1 site observation
COMPLETED
Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC)NCT00450970 · 2007-02-01 · 1 site observation
TERMINATED
A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung CancerNCT00297089 · 2006-11-01 · 1 site observation
COMPLETED
Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-PositiveNCT00390455 · 2006-09-15 · 1 site observation
COMPLETED
A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive TumorsNCT00373425 · 2006-09-01 · 1 site observation
COMPLETED
Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast CancerNCT00382070 · 2006-08-01 · 1 site observation
UNKNOWN
Study of Dose-dense Adriamycin Plus Cytoxan (AC) Followed by Either ABI-007 (Abraxane) or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast CancerNCT00394251 · 2006-08-01 · 1 site observation
COMPLETED
Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast CancerNCT00374322 · 2006-08-01 · 1 site observation
COMPLETED
S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone TherapyNCT00134056 · 2006-08-01 · 1 site observation
COMPLETED
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)NCT00310180 · 2006-04-07 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based ChemotherapyNCT00290017 · 2006-02-01 · 1 site observation
TERMINATED
PhII ICb With/Without Erbitux in MBC PtsNCT00248287 · 2005-07-28 · 1 site observation
ACTIVE_NOT_RECRUITING
Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast CancerNCT00103181 · 2005-03-01 · 1 site observation
COMPLETED
Study to Evaluate the Efficacy, Safety, and Tolerability of E7070 in Metastatic Breast Cancer PatientsNCT00080197 · 2004-02-01 · 1 site observation
COMPLETED
Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast CancerNCT00066690 · 2003-12-17 · 1 site observation
COMPLETED
Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung CancerNCT00081315 · 2003-11-01 · 1 site observation
COMPLETED
The Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast CancerNCT00065325 · 2003-08-01 · 1 site observation
COMPLETED
A Phase III Trial For Patients With Metastatic Breast CancerNCT00191152 · 2002-02-01 · 1 site observation
COMPLETED
Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung CancerNCT00008385 · 2000-12-18 · 1 site observation
COMPLETED
PROACT - Pre-Operative Arimidex Compared To TamoxifenNCT00232661 · 2000-08-01 · 1 site observation
COMPLETED
Iressa Expanded Access Program (EAP)NCT00034879 · 2000-08-01 · 1 site observation
COMPLETED
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal WomenNCT00003906 · 1999-05-01 · 1 site observation
COMPLETED
Paclitaxel and Irinotecan in Treating Patients With Advanced Non-small Cell Lung CancerNCT00004924 · 1999-03-01 · 1 site observation
COMPLETED
Study of Amrubicin With or Without Herceptin in Patients With Metastatic Breast CancerNCT00380835 · 1 site observation
WITHDRAWN
Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung CancerNCT00080340 · 2 site observations
COMPLETED
Study of Abiraterone Acetate in Patients With Advanced Prostate CancerNCT01217697 · 1 site observation
APPROVED_FOR_MARKETING
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.